BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2012
View Archived Issues
New agent for liver disorders patented by Norgine Europe
Read More
First-in-class cancer immunotherapy well tolerated in phase I trial
Read More
Novel solute carrier family 22 member 12 inhibitors designed
Read More
Bristol-Myers Squibb presents novel HIV integrase inhibitors
Read More
Taiho Pharmaceutical reports new H-PGDS inhibitors
Read More
New protein kinase inhibitors disclosed by Bayer Schering Pharma
Read More
Cell-based gene therapy is well tolerated in phase I study
Read More
CSA-131 active against Gram-negative bacteria
Read More
ARMOR1 trial assesses safety of galeterone in prostate cancer
Read More
Amgen presents first preclinical data on novel anticancer drug
Read More
New data support potential of Cell-in-a-Box technology
Read More
Novel anticancer nanomedicine shows promise in clinical trial
Read More
DARPin-based VEGF inhibitor completes phase IIa trial
Read More
Muscular Dystrophy Association awards grant to Catabasis Pharmaceuticals
Read More
Sanofi and Alfresa Pharma launch vigabatrin collaboration
Read More
Stroke biomarker license granted to Randox
Read More
Spectrum Pharmaceuticals announces acquisition
Read More
Phase III results reported for apaziquone
Read More
Amorfix establishes proof of concept for lead tumor-specific antibody
Read More
FDA approves adjunct radioactive diagnostic for Alzheimer's disease
Read More
FDA advisory committee issues recommendation on Astellas' mirabegron
Read More
Preclinical studies demonstrate small molecule's efficacy to treat anterior uveitis
Read More
Phase I/II trial begins evaluating Syndax's entinostat with lapatinib in metastatic breast cancer
Read More
Winston Pharmaceuticals receives grant to develop civamide nasal solution
Read More
Pacira Pharmaceuticals launches Exparel in U.S.
Read More
Next-generation drug-eluting stent approved in Japan to treat coronary artery disease
Read More
Pharmos reports promising data from ongoing phase IIa trial of levotofisopam
Read More